Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
1996 Jul 09;9314:7219-24. doi: 10.1073/pnas.93.14.7219.
Show Gene links
Show Anatomy links
U1 small nuclear RNA chimeric ribozymes with substrate specificity for the Rev pre-mRNA of human immunodeficiency virus.
Michienzi A
,
Prislei S
,
Bozzoni I
.
???displayArticle.abstract???
The in vivo effectiveness of ribozymes strongly depends on the correct choice of the vector molecule. High levels of expression, stability, active conformation, and correct cellular localization are the most important features for a ribozyme vector. We have exploited the utilization of the U1 small nuclear RNA (snRNA) as a vector for specifically targeting a ribozyme into the nucleus. The Rev pre-mRNA of human immunodeficiency virus type 1 was chosen as target for testing the activity of the Ul-ribozyme. The catalytic core of the hammerhead motif, plus the recognition sequences, substituted the stem-loop III of the U1 snRNA. The resulting construct displays efficient cleavage activity in vitro. In addition, in the in vivo system of Xenopus laevis oocytes, the Ul-chimeric ribozyme accumulates in large amounts in the nucleus and produces a considerable reduction of Rev pre-mRNA levels. The Rev-specific ribozyme was also inserted in a derivative of the Ul snRNA mutated in the region of pairing with the 5' splice site, such as to match it with the suboptimal splice junction of the Rev precursor. This construct shows more efficient reduction of Rev pre-mRNA in vivo than the wild-type U1 vector.
Caffarelli,
The accumulation of mature RNA for the Xenopus laevis ribosomal protein L1 is controlled at the level of splicing and turnover of the precursor RNA.
1987, Pubmed,
Xenbase
Caffarelli,
The accumulation of mature RNA for the Xenopus laevis ribosomal protein L1 is controlled at the level of splicing and turnover of the precursor RNA.
1987,
Pubmed
,
Xenbase
Cantor,
Ribozyme cleaves rex/tax mRNA and inhibits bovine leukemia virus expression.
1993,
Pubmed
Carnevali,
Nuclear factors specifically bind to upstream sequences of a Xenopus laevis ribosomal protein gene promoter.
1989,
Pubmed
,
Xenbase
Chang,
Regulation by HIV Rev depends upon recognition of splice sites.
1989,
Pubmed
Dropulic,
Ribozymes: use as anti-HIV therapeutic molecules.
1993,
Pubmed
Fischer,
Evidence that HIV-1 Rev directly promotes the nuclear export of unspliced RNA.
1994,
Pubmed
,
Xenbase
Fragapane,
Identification of the sequences responsible for the splicing phenotype of the regulatory intron of the L1 ribosomal protein gene of Xenopus laevis.
1992,
Pubmed
,
Xenbase
Fragapane,
A novel small nucleolar RNA (U16) is encoded inside a ribosomal protein intron and originates by processing of the pre-mRNA.
1993,
Pubmed
,
Xenbase
Hamm,
In vitro assembly of U1 snRNPs.
1987,
Pubmed
,
Xenbase
Haseloff,
Simple RNA enzymes with new and highly specific endoribonuclease activities.
1988,
Pubmed
Krämer,
Purification of a protein required for the splicing of pre-mRNA and its separation from the lariat debranching enzyme.
1985,
Pubmed
Leavitt,
Transfer of an anti-HIV-1 ribozyme gene into primary human lymphocytes.
1994,
Pubmed
Lerner,
Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus.
1979,
Pubmed
Ojwang,
Inhibition of human immunodeficiency virus type 1 expression by a hairpin ribozyme.
1992,
Pubmed
Patton,
U1 small nuclear ribonucleoprotein particle-specific proteins interact with the first and second stem-loops of U1 RNA, with the A protein binding directly to the RNA independently of the 70K and Sm proteins.
1989,
Pubmed
Ratner,
Complete nucleotide sequence of the AIDS virus, HTLV-III.
,
Pubmed
Ruffner,
Sequence requirements of the hammerhead RNA self-cleavage reaction.
1990,
Pubmed
Staffa,
The tat/rev intron of human immunodeficiency virus type 1 is inefficiently spliced because of suboptimal signals in the 3' splice site.
1994,
Pubmed
Stutz,
A functional interaction between Rev and yeast pre-mRNA is related to splicing complex formation.
1994,
Pubmed
Sullenger,
Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA.
1993,
Pubmed
Symons,
Small catalytic RNAs.
1992,
Pubmed
Terns,
Multiple cis-acting signals for export of pre-U1 snRNA from the nucleus.
1993,
Pubmed
,
Xenbase
Terns,
Retention and 5' cap trimethylation of U3 snRNA in the nucleus.
1994,
Pubmed
,
Xenbase
Traboni,
A general method to select for M13 clones carrying base pair substitution mutants constructed in vitro.
1983,
Pubmed
Uhlenbeck,
A small catalytic oligoribonucleotide.
,
Pubmed
Yamada,
Intracellular immunization of human T cells with a hairpin ribozyme against human immunodeficiency virus type 1.
1994,
Pubmed
Yu,
Intracellular immunization of human fetal cord blood stem/progenitor cells with a ribozyme against human immunodeficiency virus type 1.
1995,
Pubmed
Zaug,
The Tetrahymena ribozyme acts like an RNA restriction endonuclease.
,
Pubmed
Zeller,
Xenopus laevis U1 snRNA genes: characterisation of transcriptionally active genes reveals major and minor repeated gene families.
1984,
Pubmed
,
Xenbase
Zhou,
Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes.
1994,
Pubmed
